Objective: Innate immunity factors are associated with type 2 diabetes (T2DM) and its complications. Therefore, T2DM has been suggested to be an immune-dependent disease. Elevated fasting glucose level and higher concentrations of innate immunity soluble molecules are not only related with insulin resistance, but inflammation is also an important factor in beta cell dysfunction in T2DM. Toll-like receptor 2 (TLR-2), which has an important role in inducing innate immune cells, is thought to have suppressive roles on immune responses in T2DM. We therefore aimed to investigate the possible role of TLR-2 del -196-174 and Arg753Gln variants in T2DM pathogenesis.
Introduction
Diabetes is defined by hyperglycemia, resulting from defects in insulin production, activation or secretion. The high prevalence of diabetes mellitus has led to morbidity and mortality (1, 2) . The Turkish Diabetes Epidemiology Study II (TURDEP II) has reported the prevalence of diabetes mellitus at 13.7% in 2010 in Turkey (3) (4) (5) . Previous studies have suggested that innate immune system activation and low-grade chronic inflammation are involved in the pathogenesis of type 2 diabetes mellitus (T2DM) and its complications (6-10).
Toll-like receptors (TLRs) are members of the innate immunity pathway. The role of TLRs on the pathway, which initiate a signal through the nuclear factor kappa B (NF-κB), might have an impact on the development or progression of diabetes (11) . In addition, the altered expression and/or function of TLR-2 may be associated with progression and pathogenesis of immune-related diseases including T2DM and its complications (12) (13) (14) (15) .
Zhao et al. (16) reported that a high-glucose environment could induce the expression of TLR-2 and TLR-4 in retinal ganglion cells, in an attempt to elucidate the role of these genes in the etiology of diabetic retinopathy via increase in the secretion of pro-inflammatory factors. Yin et al. (17) have suggested that the role of inflammation in β-cell dysfunction may be related through the strong link between TLRs and both inflammation and autophagy. Xiong et al. (18) has shown that the TLR-2 Arg753Gln variant causes TLR2 signaling-incompetence by effecting to its tyrosine phosphorylation, dimerization and recruitment of Mal and MyD88. TLR-2 del -196-174 is a 22 bp nucleotide deletion variant that alters the promoter activity of TLR-2 (19) .
The aim of this study was to investi gate the possible role of TLR-2 del -196-174 and Arg753Gln variants in the pathogenesis of T2DM in Turkish patients.
Materials and Methods

Case selection
This case-control study was designed at the Haseki Education and Training Hospital, Department of Internal medicine (Istanbul, Turkey). After obtaining written informed consent from the participants and approval from the Ethical Committee of Haseki Education and Training Hospital (No=324/2016), blood specimens were collected in tubes containing EDTA. 
DNA isolation
Invitrogen PureLink was used to isolate genomic DNA from the blood samples.
Genotyping TLR-2 variants
TLR-2 variants were genotyped by using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. A segment of the TLR-2 gene encompassing the del -196-174 polymorphic site was amplified with specific:
pecific to a segment containing the Arg753Gln polymorphic site were also synthesised (21) . For both variants, PCR reactions were in a total volume of 25 μL containing 200 ng genomic DNA, 10 pmol of each primer, 200 ng dNTPs and 0.6 U Taq DNA polymerase. For the del -196-174 variant, DNA was denatured at 95˚C for 2 minutes, followed by 35 cycles of 94˚C for 30 seconds, 62˚C for 30 seconds and 72˚C for 30 seconds, and a final extension step at 72˚C for 5 minutes. PCR products were examined by electrophoresis on a 3% agarose gel and the del -196-174 genotypes were identified as I/I= 286 bp, I/D= 286 bp and 264 bp, and D/D= 264 bp. For the Arg753Gln variant, DNA was denatured at 95˚C for 2 minutes, followed by 35 cycles of 94˚C for 30 seconds, 57˚C for 30 seconds and 72˚C for 30 seconds, and a final extension step at 72˚C for 4 minutes. PCR products were incubated with the AciI restriction enzyme at 37˚C for 3 hours and the digested products were visualised by electrophoresis on a 3% agarose gel (GG=228, 75 bp, GA=266, 228, 75 bp and AA=266 bp).
Statistical analysis
SPSS 21.0 statistical software package (SPSS, Chicago, IL, USA) was used for statistical analyses. P<0.05 were considered to be statistically significant. We used the χ2-test to evaluate the difference in TLR-2 genotype distribution in the case and control groups. Whenever an expected cell value was less than five, Fisher's exact test was used. We compared biochemical parameters between the cases and controls by using Student's t test. Differences in biochemical parameters among the genotypes were investigated by using onne-way ANOVA and Mann-Whitney U test.
Results
Demographical parameters are shown in Table 1 (Table 4 ). In addition, we observed that HbA1c values were lower in patients with hypertension ( 7.07 ± 2.24 mg/dl) than non-hypertension (9.10 ± 3.03 mg/dl) patients (P=0.002, 95% Cl=1.74-3.32). 
Discussion
Toll-like receptors are surface proteins on eukaryotic cells to detect and respond to microbial antigens (22) . There is evidence for TLRs, especially TLR-2 and TLR-4, that they alter proinflammatory and host defense functions of human neutrophils (23) . Expression of TLR-4 and its ligand confer systemic insulin resistance in condition of elevated free fatty acids in blood (24) . Huang et al. (27) reported that SNP rs1898830 in TLR-2 is associated with T2DM risk in the Chinese population. They found that the AA genotype was associated with the secretion of pro-inflammatory cytokines and chemokines, which in turn promote inflammation in some tissues, thus resulting in insulin resistance and ultimately T2DM development (28) (29) (30) .
TLR
Maldonado-Bernal et al. (31) observed that the TLR-2 R753Q variant was very low in frequency and insignificantly less frequent in T2DM patients than in healthy donors. Wifi et al. (32) found no statistical difference in the distribution of TLR-2 -1350T/C genotypes in T2DM. In the present study, we have found a significant association for TLR-2 del -196-174 but not for the Arg753Gln gene variant in Turkish T2DM patients. We also observed an association with hypertension, however, to clarify the effect of del -196-174 genotypes on hypertension, study of patients with only hypertension will be essential.
Conclusion
Our results demonstrate that the TLR-2 is associated with increased T2DM risk. Further investigations with larger scale sample sizes are needed to confirm our findings and functional studies will be required to unravel the mechanism underlying this association.
